Protocol update and baseline characteristics for the TRIal to slow the Progression of Diabetes (TRIPOD) randomized controlled trial

Protocol update and baseline characteristics for the TRIal to slow the Progression of Diabetes (TRIPOD) randomized controlled trial

Abstract Background Type 2 diabetes (T2D), a major risk factor for cardiovascular disease and other adverse health conditions, is on the rise in Singapore. TRIPOD is a randomized controlled trial aimed to determine whether complementing usual care with an evidence-based diabetes management package (...

Full description

Bibliographic Details
Main Authors: Joann Bairavi, Daphne Su-Lyn Gardner, Ester Yeoh, Kwang Wei Tham, Mihir Gandhi, Ngiap Chuan Tan, Phong Ching Lee, Robyn Su May Lim, Thofique Adamjee, Yin Bun Cheung, Yong Mong Bee, Eric Andrew Finkelstein
Format: Article
Language:English
Published: BMC 2023-11-01
Series:Trials
Subjects:
Diabetes
Smartphone apps
mHealth
Behaviour change
Physical activity
Weight monitoring
Online Access:https://doi.org/10.1186/s13063-023-07770-7

Internet

https://doi.org/10.1186/s13063-023-07770-7

Similar Items